The treatment landscape for prevention and management of patients with HIV continues to expand and provides patients with the option for novel therapies ranging from robust single-tablet regimens to 2-drug treatments, and now, long-acting agents. Despite extensive progress in prevention and management of HIV, the COVID-19 pandemic disrupted the delivery of many advances. Although the pandemic paved the way for the rapid adoption of telehealth, it further highlighted disparities among those living with HIV. Four case studies are discussed in this activity by Drs. Badowski and Gandhi that provide insight on challenges encountered in everyday clinical practice. Their discussion highlights recent clinical advances in the use of antiretroviral therapy and preexposure prophylaxis, the role of telehealth in HIV services, and approaches to overcome health disparities. Join Drs. Badowski and Gandhi for this active dialogue to partake in a practice-based update on treatment and prevention services for patients with HIV in the era of COVID-19.
1.25 AMA PRA Category 1 CreditsTM
This activity was developed for a national audience of HIV specialists, infectious disease specialists, primary care physicians, nurse practitioners, nurses, and other healthcare professionals who care for persons living with HIV.
This educational activity is supported by an independent educational grant from ViiV Healthcare.
Melissa Badowski, PharmD, MPH, BCIDP, BCPS, AAHIVP
Clinical Associate Professor
Section of Infectious Diseases Pharmacotherapy
University of Illinois at Chicago
College of Pharmacy
Monica Gandhi, MD, MPH
Professor of Medicine and Associate Chief
Division of HIV, Infectious Diseases, and Global Medicine
Director, UCSF-Gladstone Center for AIDS Research (CFAR)
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
San Francisco, California